UNSPSC 51191578: Mannitol myleran

This classification denotes an osmotic diuretic with the molecular formula C8H18O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6STO1P091F, chemically known as cb-2511, but more generally known as mannitol myleran, which bears US NIH Compound Identifier 14464. European Medicines Agency schedules mannitol myleran or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03087MIG. Most nations, for tariff purposes, schedule mannitol myleran under HS 29054300.

SMILES: CS(=O)(=O)OC[C@H]([C@H]([C@@H]([C@@H](COS(=O)(=O)C)O)O)O)O.

UNSPSC 51191578 Mannitol myleran is a Commodity code that in recent state and local procurement activity covers pharmaceutical and chemical supply products, though the recent opportunities show substantial scope divergence from the code's nominal name. State and local governments soliciting under this code are purchasing both specialized pharmaceuticals through cooperative purchasing vehicles and chemical supplies for municipal water treatment operations. The issuing bodies include city governments and multistate cooperative purchasing alliances administering on behalf of participating state and local health and environmental agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a standout repeat buyer organizing multi-award contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon.

Recent activity spans the Upper Midwest and Connecticut. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and resulting agreements effective July 1, 2026; vendors must maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), certify cGMP and Drug Supply Chain Security Act compliance, and accept a 3 percent administrative fee. The City of Meriden, Connecticut issued IFB B027-15 in July 2026 for sodium bisulfite chemical supply for its Water Pollution Control Facility, with bids due July 29, 2026; the solicitation requires performance and payment bonds and General Liability coverage of $1,000,000 to $2,000,000. The divergence between the code's nominal pharmaceutical focus and recent water-treatment chemical procurement suggests either misclassification in the source data or inconsistent code application across jurisdictions.